Abstract:
BACKGROUND : There is limited evidence on the impact of the use of progestin-only hormonal contraception
(POC) on weight change. We conducted a secondary analysis of prospective weight change among women
enrolled in the Evidence for Contraceptive options and HIV Outcomes (ECHO) trial.
METHODS : The ECHO trial was conducted at 12 sites in eSwatini, Kenya, South Africa and Zambia between
December 2015 and October 2018. HIV negative, women aged 16 35 years, desiring contraception, were
randomised (1:1:1) to either 3-monthly intramuscular depot medroxyprogesterone acetate (DMPA-IM),
levonorgestrel (LNG) implant or copper intrauterine device (IUD). Follow-up was up to 18 months. Weight
(kg) was measured at baseline and study exit. Analysis was performed as intention to treat (ITT) and time on
continuous contraceptive use. The primary outcome of this secondary analysis is weight change from study
enrolment to the final visit at study month 12 18. The ECHO trial is registered with ClinicalTrials.gov,
NCT02550067.
FINDINGS : 7829 women were randomly assigned to DMPA-IM (n = 2609), copper IUD (n = 2607) or LNG
implant (n = 2613). The ITT population included 7014 women 2293 DMPA-IM group, 2372 copper IUD group
and 2349 LNG group) who were not lost to follow-up, pregnant on study, or missing weight data. The mean
weight increased in all groups but was significantly different in magnitude: 3.5 kg (SD = 6.3), 2.4 kg (SD = 5.9)
and 1.5 kg (SD = 5.7) in the DMPA-IM, LNG implant and copper IUD groups, respectively. Comparative differences
between groups were (2.02 kg (95% CI, 1.68, 2.36, p < 0.001) for DMPA-IM versus copper IUD, 0.87 kg
(0.53,1.20 p < 0.001) for LNG implant compared to copper IUD and 1.16 kg (0.82, 1.50, p < 0.001) for DMPAIM
compared with LNG implant. Results for continuous contraceptive use were similar.
INTERPRETATION : We found differences in weight gain between POC users compared to the non-hormonal copper
IUD group over 12 18 months of use. Women using POCs should be counselled about this potential side
effect when choosing a contraceptive method.